Medicenna Therapeutics Corp.
MDNAF
$0.56
$0.012.01%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 11.84% | 5.16% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.43% | -0.26% | |||
| Operating Income | -1.43% | 0.26% | |||
| Income Before Tax | 11.71% | 0.46% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 11.71% | 0.46% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 11.71% | 0.46% | |||
| EBIT | -1.43% | 0.26% | |||
| EBITDA | -1.54% | 0.06% | |||
| EPS Basic | 11.76% | 1.62% | |||
| Normalized Basic EPS | 11.65% | 1.48% | |||
| EPS Diluted | 11.76% | 1.62% | |||
| Normalized Diluted EPS | 11.65% | 1.48% | |||
| Average Basic Shares Outstanding | 0.01% | 1.07% | |||
| Average Diluted Shares Outstanding | 0.01% | 1.07% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||